R R

What Is Lyophilized Powder?

Lyophilized powder is a dry pharmaceutical product made by removing water from a frozen solution under reduced pressure. This process is also called lyophilization or freeze-drying. It can improve the storage stability of medicines, biologics, and vaccines that are less stable in liquid form. Many lyophilized products must be mixed with a specified liquid before they can be administered.

Link to This Resource Page

Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.

To display this...

What Is Lyophilized Powder?

Lyophilized powder is a dry pharmaceutical product made by removing water from a frozen solution under reduced pressure. This process is also called lyophilization or freeze-drying. It can improve the storage stability of medicines, biologics, and vaccines that are less stable in liquid form. Many lyophilized products must be mixed with a specified liquid before they can be administered.

read more about lyophilized powder ...

Copy this HTML:

Copy HTML Copied!

How Is Lyophilized Powder Made?

The product solution is first frozen so that much of its water forms ice. During primary drying, reduced pressure allows the ice to change directly from a solid into vapor through sublimation. Secondary drying removes additional moisture that remains attached to the product. The resulting material is a dry powder or porous cake sealed in a vial or another suitable container.

Why Are Medicines Lyophilized?

Removing water can slow chemical reactions and physical changes that damage sensitive ingredients. Lyophilization can extend shelf life and make some products easier to store or transport. It is commonly used for proteins, antibodies, vaccines, antibiotics, and other products that do not remain stable as liquids. The process does not make every medicine stable at room temperature, so labeled storage conditions still apply.

How Is Lyophilized Powder Reconstituted?

Reconstitution means adding the exact diluent and volume stated in the product instructions. The vial can require gentle swirling rather than vigorous shaking, especially for sensitive biological medicines. The prepared solution should be inspected for unexpected particles, cloudiness, discoloration, or incomplete dissolution when the label directs. Only the approved diluent, technique, dose, route, and time limit after mixing should be used.

What Are the Storage and Safety Precautions?

Unopened lyophilized products must be stored at the temperature and light conditions shown on the label. Stability can change substantially after reconstitution, and some products must be used immediately or within a short refrigerated period. Sterile technique is required for injectable products to prevent contamination. A product should be discarded when the vial is damaged, the expiration date has passed, or the reconstituted solution does not meet the labeled appearance requirements.

Frequently Asked Questions About Lyophilized Powder

Is lyophilized powder the same as regular powder?

No. Lyophilized powder is produced from a frozen solution through a controlled freeze-drying process. Its structure and moisture content are designed to protect a specific pharmaceutical product.

Does lyophilized powder need to be refrigerated?

Some products require refrigeration, while others are stored at controlled room temperature. The product label is the correct source for storage requirements before and after reconstitution.

Can any liquid be used to reconstitute lyophilized powder?

No. The wrong liquid or volume can damage the medicine, change its concentration, or make it unsafe. Only the diluent specified by the manufacturer should be used.

How long is a reconstituted product usable?

The allowed time ranges from immediate use to a defined period under specified storage conditions. Any unused product should be discarded when the labeled time limit has passed.

References

Lyophilization of Parenteral (7/93). U.S. Food and Drug Administration. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/inspection-guides/lyophilization-parenteral-793. Date Accessed August 5, 2026.

New Trends in Freeze-Drying of Pharmaceutical Products. Pharmaceutics (PubMed Central). https://pmc.ncbi.nlm.nih.gov/articles/PMC10383798/. Date Accessed August 5, 2026.

Practical Advice on Scientific Design of a Freeze-Drying Process: 2023 Update. AAPS PharmSciTech (PubMed Central). https://pmc.ncbi.nlm.nih.gov/articles/PMC10661802/. Date Accessed August 5, 2026.

Maximum Shelf-Life for Sterile Products for Human Use After First Opening or Following Reconstitution. European Medicines Agency. https://www.ema.europa.eu/en/maximum-shelf-life-sterile-products-human-use-after-first-opening-or-following-reconstitution-scientific-guideline. Date Accessed August 5, 2026.

M-M-R II (Measles, Mumps, and Rubella Virus Vaccine Live) Package Insert. U.S. Food and Drug Administration. https://www.fda.gov/files/vaccines%2C%20blood%20%26%20biologics/published/Package-Insert-Measles-Mumps-and-Rubella-Virus-Vaccine-Live_2.pdf. Date Accessed August 5, 2026.